INTEGRITI-(TIMI 20) evaluated the safety and efficacy of the combination of eptifibatide and TNK among 438 patients presenting with ST elevation myocardial infarction.
MAIN RESULTS:
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial

J Am Coll Cardiol. 2003 Apr 16;41(8):1251-60.
PRESENTATIONS
INTEGRITI Main Results
TIMI 20 Slides